جست‌وجوی استاد و پژوهشگر

• Bacterial Pathogenesis
• Host-Pathogen Interactions
• Vaccine Development
• +۳ مورد دیگر

Mary Burtnick is a Professor in the Department of Microbiology and Immunology at the University of Nevada, Reno. Her research focuses on the molecular mechanisms of Burkholderia pseudomallei pathogenesis, particularly its intracellular survival strategies and secretion systems. She has over 20 years of expertise in bacterial genetics, host-pathogen interactions, and antigen discovery. Education : B.Sc., Biology, University of British Columbia Ph.D., Bacterial Pathogenesis, University of Calgary Her work aims to develop vaccines and diagnostics for melioidosis by analyzing host-pathogen dynamics. Recent publications highlight advancements in capsular polysaccharide-based vaccines, immunoassay development, and integrated medical countermeasures against Burkholderia infections. Key scientific contributions include collaborations on antigenic epitope characterization, biofilm regulation, and immunogenicity of bacterial proteins. Her lab employs murine models to study pathogen clearance and immune response mechanisms.

• Sleep and Chronobiology
• Neurobehavioral Functions
• Behavioral Neuroscience
• +۴ مورد دیگر

David F. Dinges, Ph.D., is Professor of Psychiatry at the University of Pennsylvania's Perelman School of Medicine. He serves as Director of the Unit for Experimental Psychiatry, Chief of the Division of Sleep and Chronobiology, and Associate Director of the Center for Sleep and Circadian Neurobiology. His affiliations include the Neuroscience Graduate Group, Psychology Graduate Group, and multiple interdisciplinary research centers. Education: A.B. in Psychology, St. Benedict's College (1971) M.S. and Ph.D. in Physiological Psychology, Saint Louis University (1974, 1976) M.A. (Honorary), University of Pennsylvania (1993) Dr. Dinges leads translational research on neurobehavioral regulation by sleep and circadian biology, using methodologies including cognitive testing, neuroimaging, electrophysiology, and biomarker analysis. His work examines vulnerability to sleep loss, recovery dynamics, and fatigue countermeasures in safety-critical occupations including spaceflight, aviation, and healthcare. He developed the widely used Psychomotor Vigilance Test (PVT). His publications focus on sleep physiology, neurobehavioral performance, and fatigue risk management in operational environments. Core themes include biomarker discovery, individual differences in sleep vulnerability, and technological solutions for fatigue mitigation. Awards: NASA Distinguished Public Service Medal (2007) Distinguished Scientist Award, Sleep Research Society (2018) Nathaniel Kleitman Distinguished Service Award (2017) Pioneer Award, National Space Biomedical Research Institute (2016) He directs the Unit for Experimental Psychiatry laboratory, which conducts controlled studies in the Hospital of Pennsylvania's Sleep and Chronobiology Laboratory and field research in extreme environments. His team develops neurobehavioral technologies for clinical and occupational applications, supported by NASA, NIH, and FAA grants. He mentors trainees at all career stages.

• Molecular Imaging
• Positron Emission Tomography (PET)
• Cancer Research
• +۵ مورد دیگر

Jesper Tranekjær Jørgensen serves as a Guest Researcher at the Department of Biomedical Sciences, University of Copenhagen, within the Cluster for Molecular Imaging under the Faculty of Health and Medical Sciences. His research focuses on advancing molecular imaging techniques, particularly positron emission tomography (PET), for applications in oncology and cardiovascular disease diagnostics. His academic journey includes PhD training (2008-2013) and postdoctoral research (2013-present) at the University of Copenhagen's Department of Clinical Physiology, Nuclear Medicine and PET, following initial work as a Research Assistant (2007-2008). His expertise spans molecular imaging probe development, radiopharmaceutical chemistry, and translational applications of PET technology. Dr. Jørgensen's research portfolio demonstrates significant contributions to bioorthogonal chemistry for pretargeted imaging , blood-brain barrier modulation strategies , and nanobody-based viral therapeutics . His recent publications reveal a strong emphasis on developing novel radiotracers (including 211At-labeled tetrazines , 18F-labeled compounds , and 11C-tucatinib ), with applications spanning cancer theranostics, neuroimaging, and infectious disease countermeasures. Key methodological innovations include gold nanoshell photothermal therapy integration and somatostatin receptor targeting approaches. As part of the Cluster for Molecular Imaging, he collaborates extensively across virology, oncology, and nanomedicine domains, with research outputs showing substantial real-world impact through patent references and social media dissemination. His work bridges fundamental radiochemistry with clinical applications, particularly in tumor targeting and cardiovascular pathophysiology.

• Exercise Physiology
• Cardiovascular Physiology
• Autonomic Neuroscience
• +۳ مورد دیگر

Lonnie Grove Petersen is an international researcher at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen. His work focuses on human physiological adaptations in extreme environments, particularly spaceflight and exercise stressors, with significant contributions to understanding cardiovascular, ocular, and thrombotic risks in microgravity. His research spans Exercise Physiology, Cardiovascular Regulation, Autonomic Neuroscience, and Space Medicine. Key investigations include neuro-ocular syndrome in astronauts, exercise-induced hormonal responses, and autonomic control mechanisms during gravitational stress. His methodology integrates human subject studies with translational approaches to address health challenges in space exploration and terrestrial applications. Analysis of his 2023-2025 publications reveals a dominant focus on space medicine, especially Spaceflight Associated Neuro-ocular Syndrome (SANS) and venous thrombosis risks. His work demonstrates strong interdisciplinary collaboration across cardiovascular physiology, exercise science, and aerospace medicine, with frequent use of human experimental models like lower body negative pressure and high-intensity exercise protocols. No scientific awards are explicitly documented in the provided information. While graduate student mentorship details are absent, Petersen maintains extensive international collaborations, particularly with European and North American space research institutions. His publication record indicates active grant-funded research, though specific funding sources are not disclosed in the source material. His research operates within Copenhagen's Department of Biomedical Sciences, leveraging the university's human physiology infrastructure. Collaborative networks include the European Space Agency-affiliated projects and multinational teams studying microgravity pathophysiology, with emphasis on developing countermeasures for long-duration space missions.

Cham Tat Hueiمشاهده پروفایل

استاد

• Marketing
• Consumer behaviour
• Business management
• +۹ مورد دیگر

Professor Cham Tat Huei is a distinguished academic serving as Professor of Marketing and accredited PhD Supervisor at Swinburne University of Technology (Malaysia campus), a university ranked 291st in the QS World University Rankings 2025. His academic leadership extends globally through visiting professorships at prestigious institutions across Asia, including Tashkent State University of Economics (Uzbekistan), Chongqing University of Arts and Sciences (China), Universitas Multimedia Nusantara (Indonesia), Sohar University (Oman), and Qiannan Normal University for Nationalities (China). His research expertise spans multiple business domains with particular focus on digital transformation, consumer behavior in technology-driven environments, and strategic service innovation. Professor Cham has published over 80 peer-reviewed papers in high-impact journals, with three articles recognized as Highly Cited Papers by Web of Science. His work appears in top journals including Journal of Business Research, Journal of Retailing and Consumer Services, and International Journal of Tourism Research. Professor Cham's academic leadership is evident through his editorial roles as Editor-in-Chief of two journals and membership on multiple editorial boards. His research excellence has been recognized through numerous awards including being named among the World's Top 2% Scientists by Stanford University and Elsevier, the National Outstanding Young Educator Award, and multiple Best Paper Awards from international conferences. He actively supervises doctoral and Master's students, with 19 completed doctorates, 7 in progress, and 28 completed Master's theses. World's Top 2% Scientists by Stanford University and Elsevier Member of Young Scientists Network-Academy of Sciences Malaysia (YSN-ASM) National Outstanding Young Educator Award by EduCoop Malaysia UTAR Outstanding Alumni Award (Professional, Academic, and Research Excellence category) Emerald Literati Award 2024 for Outstanding Reviewer Multiple Best Paper Awards from international conferences Top citation and download awards from leading academic journals Professor Cham maintains an active role in academic quality assurance as an External Examiner for numerous international institutions and serves as a Certified Trainer for Alibaba.com, HRDF, and MDEC. His research continues to evolve with current trends in AI, metaverse commerce, and digital transformation across multiple industries.

Ramin M. Hakamiمشاهده پروفایل

دانشیار

• Innate Immunity
• Extracellular Vesicles
• Host-Pathogen Interactions
• +۳ مورد دیگر

Dr. Ramin M. Hakami serves as Associate Professor in the School of Systems Biology within George Mason University's College of Science. His research laboratory investigates fundamental mechanisms of vesicular trafficking and extracellular vesicle (EV) regulation of innate immune responses during infections with Category A pathogens including Yersinia pestis, Burkholderia pseudomallei, Rift Valley fever virus, and SARS-CoV-2. Current work focuses on developing host-based countermeasures through EV-mediated immune modulation. Education: Ph.D. in Biochemistry from Massachusetts Institute of Technology (MIT) under Nobel Laureate Har Gobind Khorana Postdoctoral training at Harvard Medical School with NIH NRSA fellowship Dr. Hakami's research program centers on EV-mediated host-pathogen interactions, specifically how infection-derived EVs (EXi) carry pathogen components to regulate innate immunity. His lab pioneered methods for purifying EXi from infected cells and demonstrated their protective roles through RIG-I-dependent IFN-β activation and autophagy. Current projects include developing microfluidic platforms for real-time EV exchange monitoring and repurposing HSP90 inhibitors for viral infections. The overarching goal is identifying novel therapeutic targets against pathogens lacking effective countermeasures. Publication analysis reveals dominant themes in EV biology across infectious diseases and neurological disorders. His work bridges virology, bacteriology, and neuroscience with emphasis on EXi-mediated protection, microfluidic EV analysis, and host factor targeting. Key trends include EV cargo characterization during infection, real-time EV tracking methodologies, and therapeutic applications of EV research for high-consequence pathogens. Scientific Awards: 2022 Dean’s Impact Award nominee (College of Science) 2016 & 2015 Nominated for GMU OSCAR Mentoring Excellence Award 2003 NIH Fellows Award for Research Excellence 1996 NIH Ruth L. Kirschstein National Research Service Award Multiple undergraduate awards from Stony Brook University Dr. Hakami secured STTR Phase I and Phase II NIH grants for developing a novel immunotherapeutic platform against toxigenic bacterial pathogens in collaboration with Integrated Biotherapeutics, Inc. and University of Maryland. His mentoring excellence nominations reflect active student supervision, while ongoing projects include transitioning EXi studies to in vivo models for anthrax and melioidosis. Current grant activities focus on advancing EV-based technologies toward investigational new drug (IND) status. The Hakami Lab operates from the Biomedical Research Lab at GMU's SciTech campus, collaborating with the Center for Infectious Disease Research (CIDR) and Department of Bioengineering. Key initiatives include the EV microfluidic platform development and herbal treatment studies for COVID-19. The lab maintains partnerships with Harvard Medical School, NIH, and industry groups for therapeutic translation, with recent work featured in Mason research news for anthrax breakthroughs and EV vaccine development.

• Neuroscience
• Epilepsy Research
• Neuropsychiatric Disorders
• +۵ مورد دیگر

Dr. Vassiliki Aroniadou-Anderjaska is a Research Professor in the Department of Anatomy, Physiology and Genetics at the Uniformed Services University of the Health Sciences (USUHS) School of Medicine. With over 30 years of neuroscience research experience, her work spans synaptic plasticity, amygdala physiology, and nerve agent countermeasure development. Her educational background includes a Ph.D. in Neuroscience (1991) from Kent State University and Northeastern Ohio Universities College of Medicine, a Master's in Exercise Physiology (1987) from Kent State University, and a B.A. from the University of Athens (1982). Dr. Aroniadou-Anderjaska's research focuses on three primary areas: 1) Developing medical countermeasures against nerve agent toxicity, including the discovery of LY293558 (Tezampanel) as an anticonvulsant/neuroprotectant; 2) Investigating amygdala physiology with implications for epilepsy, anxiety disorders, schizophrenia, and autism; 3) Elucidating learning and memory mechanisms at cellular/molecular levels. Her recent work (2012-2018) reveals critical roles of NR2A-NMDA receptors, ASIC1a channels, and GluK1 receptors in amygdala circuitry regulation. Earlier studies (1999-2011) established foundational knowledge on olfactory bulb physiology, synaptic plasticity, and nerve agent mechanisms. Her research has directly led to the creation of Proniras, a company funded by BARDA to advance nerve agent countermeasures. Collaborative grants with Dr. Maria Braga have produced significant insights into stress-epilepsy interactions and novel therapeutic targets. Current laboratory work examines rhythmic inhibition in the basolateral amygdala, acid-sensing ion channels in anxiety regulation, and delayed-treatment strategies for nerve agent exposure. The team maintains active research programs in both basic neuroscience and translational medical countermeasure development.

Maria F. Bragaمشاهده پروفایل

استاد

• Neuroscience
• Neuropharmacology
• Anxiety Disorders
• +۶ مورد دیگر

Maria F. Braga, D.D.S., Ph.D., is a Professor in the Department of Anatomy, Physiology and Genetics at the Uniformed Services University of the Health Sciences (USU) School of Medicine, Bethesda, MD. Her primary research focuses on neuronal mechanisms within the amygdala relevant to anxiety disorders, epilepsy, and traumatic brain injury. Education: D.D.S. from Federal University of Alagoas, Brazil Ph.D. in Physiology and Pharmacology from University of Strathclyde, Scotland, UK Postdoctoral Fellowship at University of Maryland School of Medicine, USA Dr. Braga's research centers on amygdala function, investigating how GABAergic and glutamatergic systems regulate neuronal excitability in emotional disorders and epilepsy. Her laboratory employs electrophysiological techniques (patch-clamp, field potential recordings) and molecular methods to study synaptic transmission in normal and pathological states. Key discoveries include identifying GluR5 kainate receptors as critical regulators of amygdala excitability and demonstrating that reduced GABAergic inhibition underlies anxiety after mild traumatic brain injury (mTBI). Her work on nerve agent countermeasures revealed Tezampanel's efficacy against soman-induced seizures, leading to an $89.5 million BARDA contract for advanced development. Analysis of her recent publications reveals consistent focus on amygdala pathophysiology across three major research thrusts: (1) anxiety disorder mechanisms involving ASIC1a channels and GABA/glutamate balance, (2) mTBI-induced GABAergic deficits linking to delayed anxiety symptoms, and (3) nerve agent countermeasures targeting kainate receptors. The interdisciplinary nature spans molecular neuroscience, electrophysiology, and translational pharmacology with strong military medical relevance. Major Recognition: BARDA $89.5 million contract (2018) for Tezampanel development against nerve agent-induced seizures Society for Neuroscience press coverage of amygdala acidity research (2014) Extensive NIH/NINDS funding for epilepsy and TBI research Dr. Braga leads the USUHS-NIMH Center for Neuroscience and Regenerative Medicine consortium studying mTBI mechanisms. Her laboratory has trained numerous neuroscience graduate students who co-authored key publications. Current research focuses on developing GluR5 kainate receptor antagonists as antiepileptogenic treatments and establishing causal links between initial brain insults and long-term neuronal dysfunction. The team maintains active collaborations with NIMH and military medical research units to translate basic findings into clinical applications for service members.

• Medical Pharmacology
• Toxicology
• Mushroom Toxins Research
• +۴ مورد دیگر

Prof. Dr. ERTUĞRUL KAYA is a Professor of Medical Pharmacology at Niğdge Ömer Halisdemir University Faculty of Medicine, having joined in 2023 after serving at Düzce University Faculty of Medicine from 2010-2023. His academic career progressed from Doctor Lecturer (2010-2014) to Associate Professor (2014-2020) and finally to Professor (2020-present). He has held significant administrative roles including Head of Department and Research Application Center Director. Education: Medical Specialization: Pamukkale University, Faculty of Medicine/Department of Internal Medical Sciences/Department of Medical Pharmacology (2002-2006) Thesis: Behavioral and biochemical effects of minocycline and nilvadipine in rats with cerebral ischemia induced by repeated four-vessel occlusion method Licence: Istanbul University, Istanbul Faculty of Medicine/Medicine Pr. (1992-1998) Prof. Kaya's research primarily focuses on toxicology, particularly mushroom toxins (amanitins, phallotoxins, grayanotoxins), pharmacological interventions for toxin-induced damage, and analytical methods for toxin detection. His work spans pharmacokinetics, hepatotoxicity, neurotoxicity, and the development of antidotes for mushroom poisoning. He has extensively studied Amanita species, Galerina marginata, and mad honey (grayanotoxin) toxicity, examining both the mechanisms of toxicity and potential therapeutic interventions using natural compounds and pharmaceutical agents. His 15 most recent publications demonstrate a strong emphasis on mycotoxicology, with particular focus on amatoxins, analytical methods for toxin detection, and therapeutic interventions. His research combines molecular biology, cell culture studies, animal models, and clinical case analyses to understand toxic mechanisms and develop countermeasures. A significant portion of his work addresses forensic applications of toxin analysis and the development of diagnostic tools for mushroom poisoning cases. Research Advising: Supervised 6 graduate students on topics including Amanita phalloides toxins, grayanotoxin effects, and antimicrobial properties of mushroom extracts Research projects span pharmacological effects of toxins, analytical methods, and potential therapeutic interventions Research Projects: Currently leading 2 ongoing projects related to regional honey analysis and experimental hypertension models Completed 25+ research projects primarily focused on mushroom toxins, amanitin pharmacokinetics, and analytical methods Secured funding from TÜBİTAK and university-supported research programs Prof. Kaya has developed patented diagnostic tools for mushroom poisoning, including an immunochromatographic card test for alpha-amanitin detection and gamma thiolactone derivatives for amanitin poisoning treatment. His work bridges laboratory research with clinical applications in toxicology and emergency medicine.

• Space physiology and medicine
• Central auditory processing
• Hyperbaric medicine
• +۵ مورد دیگر

Jay C. Buckey Jr is a Professor of Medicine at the Geisel School of Medicine at Dartmouth College. He serves as Director of the Space Medicine Innovations Laboratory and holds an additional appointment as Adjunct Professor at the Thayer School of Engineering. Dr. Buckey received his BSEE from Cornell University in 1977 and his MD from Cornell University Medical College in 1981. His research spans multiple domains at the intersection of space medicine, neuroscience, and innovative healthcare technologies. Dr. Buckey's work focuses on central auditory processing as a marker of neurocognitive function, space physiology and medicine, hyperbaric medicine, audiology and hearing assessment, computer-based psychological training programs, visual changes after spaceflight, and virtual reality applications. His research has significant implications for both space exploration and terrestrial medical applications, particularly in isolated and confined environments. Dr. Buckey's recent publications demonstrate a strong focus on space medicine, auditory neuroscience, and applications of technology in healthcare. His work bridges the gap between space exploration research and practical medical applications on Earth, with particular emphasis on developing innovative diagnostic tools and treatment approaches for conditions affecting astronauts and patients in remote settings. As Director of the Space Medicine Innovations Laboratory, Dr. Buckey leads a multidisciplinary research team with global reach. The laboratory focuses on assessing brain function using the auditory system in various patient populations, developing new audiological tests for global use, creating autonomous behavioral health tools for isolated environments, and exploring hyperbaric oxygen applications. The lab also conducts technology and science projects for NASA and the Department of Defense. Dr. Buckey is the author of the book "Space Physiology" published by Oxford University Press and co-author of "The Neurolab Spacelab Mission: Neuroscience Research in Space," documenting results from the STS-90 mission.

Christof Paarمشاهده پروفایل

استاد

• Cryptography
• Hardware Security
• Embedded Systems Security
• +۷ مورد دیگر

Professor Christof Paar is a Research Professor at Ruhr University Bochum, Faculty of Computer Science, where he leads the Embedded Security group. His work bridges theoretical cryptography with practical implementation security for embedded systems, with a strong emphasis on real-world security challenges. Professor Paar's research focuses on multiple critical areas of security including hardware security, side-channel attacks, hardware trojans, physical-layer security, wireless security, and reverse engineering. His work is characterized by a strong practical orientation, often demonstrating real-world vulnerabilities and developing practical countermeasures. He has made significant contributions to understanding and improving the security of cryptographic implementations in resource-constrained environments. His publication record shows a consistent output of high-quality research, with particular emphasis in recent years on physical-layer security, wireless security, hardware reverse engineering, and hardware trojan detection. His work spans both theoretical contributions to cryptographic engineering and practical demonstrations of security vulnerabilities in real systems. Professor Paar's educational impact is substantial, having co-authored the widely used textbook 'Understanding Cryptography' and offering numerous courses at both undergraduate and graduate levels. His group actively engages students through Bachelor and Master projects, providing hands-on experience with cutting-edge security research topics. His lab, the Embedded Security group, appears to maintain an active research program with multiple ongoing projects in hardware and embedded systems security. The group collaborates internationally and publishes regularly in top security venues, maintaining a strong presence in the cryptographic engineering community.

• Serotonin receptor pharmacology
• Psychedelic drug discovery
• G protein-coupled receptor (GPCR) signaling
• +۵ مورد دیگر

Dr. John McCorvy is an Associate Professor at the Medical College of Wisconsin with joint appointments in the Department of Cell Biology, Neurobiology and Anatomy and the Department of Pharmacology and Toxicology. He is an active member of both the Neuroscience Research Center and Cancer Center, where his research bridges structural biology, medicinal chemistry, and neuropharmacology. Dr. McCorvy's research focuses on serotonin receptor pharmacology, particularly the 5-HT 2 family, with emphasis on understanding the molecular mechanisms of psychedelic drug action. His laboratory investigates G protein-coupled receptor (GPCR) signaling, biased agonism, and structure-based drug design to develop novel therapeutics for mental health disorders. His work has led to significant advances in understanding how psychedelic compounds interact with serotonin receptors at the atomic level and how this knowledge can be leveraged to create next-generation therapeutics with improved safety profiles. With over 85 publications spanning high-impact journals including Nature, Science, and Cell, Dr. McCorvy has established himself as a leader in GPCR pharmacology and psychedelic science. His recent work has focused on identifying specific signaling pathways associated with the therapeutic potential of psychedelics while minimizing hallucinogenic effects. Outstanding Graduate School Educator, Medical College of Wisconsin (2020-2022) Neuroscience Research Center Excellence Award (2019) Postdoctoral Scholar Award, UNC Pharmacology Department (2016) Best Poster Prize, Great Lakes GPCR Retreat (2015) As a principal investigator, Dr. McCorvy currently leads multiple NIH-funded projects totaling over $5 million in direct funding, including R01 grants from NIMH, NIGMS, and NIDA. He mentors several PhD students and postdoctoral researchers, with a strong track record of student success including national presentations and peer-reviewed publications. His lab maintains active collaborations with both academic institutions and industry partners working in the psychedelic therapeutics space. Dr. McCorvy's laboratory employs a multidisciplinary approach combining structural biology, computational modeling, medicinal chemistry, and pharmacological characterization to advance our understanding of serotonin receptor function and develop novel therapeutic strategies for mental health disorders.

• Global Health Governance
• Health Security
• Pharmaceutical Policy
• +۵ مورد دیگر

Anne Roemer-Mahler is an Associate Professor in International Relations at the School of Global Studies, University of Sussex, where she also serves as Deputy Director of the Centre for Global Health Policy. Originally from Germany, she completed her DPhil at the Oxford Department of International Development and previously worked as a Research Fellow at the London School of Hygiene and Tropical Medicine (LSHTM). Her academic career spans over a decade at Sussex, where she has established herself as a leading scholar at the intersection of international relations and global health governance. Her educational background includes: DPhil (PhD) from the University of Oxford MPhil from the University of Oxford MA from the University of Hamburg, Germany Fellow of the Higher Education Academy (FHEA) Anne's research program centers on global health governance, with particular emphasis on health security, access to medicines, and the role of pharmaceuticals in global health contexts. Her work takes historical approaches and incorporates decolonial/postcolonial analyses to examine how health has become understood as a 'global' issue shaped by social and political processes. She has conducted extensive research on the role of the Indian pharmaceutical industry in HIV/AIDS access to medicines debates and more recently has focused on 'health security' in Africa, particularly the emergence of the Africa Centers for Disease Control and Prevention (Africa CDC). Her current research examines antibiotic resistance through a One Health lens in the Nile Valley region (Egypt, Sudan, and Ethiopia). Her publication record shows consistent output in high-impact journals, with articles in International Affairs, Third World Quarterly, Social Science & Medicine, and Security Dialogue. Her work demonstrates how global health governance reflects broader power dynamics in international relations, with particular attention to how African perspectives are reshaping traditional global health architectures. Her research on Ebola, pharmaceutical policy, and antimicrobial resistance has been widely cited and has influenced academic and policy debates. Her research funding includes multiple grants from prestigious organizations: Academy of Medical Sciences: 'One Health Platform to Reduce the Emergence and Spread of Antibiotic Resistance in the Nile Valley' (2020-2022) Wellcome Trust: 'How to study the politics of global health security?' (2020-2021) National Institute for Health Research: 'Social Sciences for Severe Stigmatising Skin Diseases' (2019-2023) British Academy: 'Collaborating for Global Health Security: The new Africa CDC' (2018-2019) She teaches 'Business in World Politics,' 'The Global Politics of Health,' and 'The International Politics of Health,' where she explores how companies shape global politics, how health is shaped by social and political processes, and the historical and political dimensions of global health. She welcomes PhD students working on global health governance, particularly those with interests in historical approaches, decolonial/postcolonial analyses, health security in Africa, and the role of technologies in global health governance.

Heather Himburgمشاهده پروفایل

استاد

• Radiation Biology
• Cancer Stem Cell Biology
• Hematopoiesis
• +۲ مورد دیگر

Heather Himburg, PhD, serves as Professor in the Department of Radiation Oncology at the Medical College of Wisconsin (MCW), where her research focuses on radiation biology and therapeutic development for radiation injury mitigation. Her work bridges translational science and clinical applications in radiation oncology. Education: PhD in Biomedical Engineering, Duke University, 2005 MS in Biomedical Engineering, Ohio State University, 2001 BS in Physics, Miami University, 1998 Research Focus: Dr. Himburg's laboratory investigates acute and delayed radiation effects on multiple organ systems, with specialization in vascular injury mechanisms and bone marrow microenvironment dynamics. Her team develops countermeasures for hematopoietic acute radiation syndrome and studies cancer stem cell biology to improve radiation therapy safety. Current projects target radioprotective therapeutics for bone marrow, heart, lung, and kidney tissues using preclinical models established by MCW emeritus researchers Meetha Medhora and John Moulder. Publication Analysis: Her 2024-2025 publications reveal dominant themes in head and neck cancer therapeutics, radiation-induced organ toxicity, and immune modulation. Key trends include molecular radiosensitization strategies (CXCL12 pathways), advanced imaging for treatment response monitoring, and novel countermeasures for radiation syndromes. The work consistently integrates translational approaches from in vitro models to rodent studies, emphasizing clinical applicability in radiation oncology. Laboratory Structure: The Himburg Laboratory (MFRC 4072/4004 lab, 4076 office) operates as a collaborative hub with Brian Fish directing the Precision Irradiation Core. The team comprises research scientists, technologists, and coordinators specializing in vascular biology, stem cell assays, and radiation countermeasure development, supporting MCW's radiation oncology research infrastructure through the ROCKET Program.

• Biomechanics
• Unmanned Systems
• Medical Rehabilitation
• +۵ مورد دیگر

Dr. Christine Walck is an Assistant Professor in the Department of Mechanical Engineering at Embry-Riddle Aeronautical University's College of Engineering. She joined ERAU in 2019 after serving as a Mechanical Engineer at the U.S. Naval Research Laboratory (2011-2018), where she specialized in unmanned systems and decoy technologies. As the primary investigator of the Embry-Riddle Biomechanical Analyses Laboratory (ERBAL), she conducts interdisciplinary research spanning biomechanics, human performance optimization, and medical rehabilitation. Her research integrates mechanical engineering with neuroscience and computer science to: Analyze muscle function and human movement patterns Develop enhanced rehabilitation protocols Design assistive medical devices and orthotics Create aerospace countermeasures for microgravity effects Engineer robotic systems for research and education Dr. Walck's recent publications demonstrate strong focus areas in knee biomechanics (including ACL rehabilitation and orthotic design), ligament modeling techniques, assistive sports technologies, and educational robotics. Her work frequently appears in biomechanics and orthopedic journals, with recent studies exploring patient-specific modeling approaches and cross-disciplinary applications between aerospace and biomedical engineering. She has received multiple recognitions including: Best Poster Award (Fall & Spring 2023-2024) Most Outstanding Teaching Award Nominee (Spring 2024) Mechanical Engineering Outstanding Service Award (2023) Dr. Walck actively teaches core mechanical engineering courses including Dynamics and Fundamentals of Biomechanics, while supervising graduate theses. She maintains professional engagements through peer review activities, committee memberships for the College of Arts and Sciences, and mentorship roles in student organizations like the EagleNauts Club.